Showing results (51-60 of 90) with videos related to

Sort By:
Pageof 9
American Journal of Clinical Pathology|June 15, 2013
Dense pattern of embryonal rhabdomyosarcoma, a lesion easily confused with alveolar rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology GroupErin R Rudzinski, Lisa A Teot, James R Anderson, et al.
Cancer Genetics|December 20, 2021
Diagnostic testing approaches for the identification of patients with TRK fusion cancer prior to enrollment in clinical trials investigating larotrectinibErin R Rudzinski, Jaclyn Hechtman, Sinchita Roy-Chowdhuri, et al.
European Journal of Cancer (Oxford, England : 1990)|December 10, 2020
The prognostic significance of anaplasia in childhood rhabdomyosarcoma: A report from the Children's Oncology GroupArchana Shenoy, Elysia Alvarez, Yueh-Yun Chi, et al.
Archives of Pathology & Laboratory Medicine|May 17, 2023
The Pathologic Diagnosis of Pediatric Soft Tissue Tumors in the Era of Molecular Medicine: The Sarcoma Pediatric Pathology Research Interest Group PerspectiveJennifer O Black, Alyaa Al-Ibraheemi, Michael A Arnold, et al.
JAMA Otolaryngology-- Head & Neck Surgery|July 3, 2020
Targeted Oncogene Therapy Before Surgery in Pediatric Patients With Advanced Invasive Thyroid Cancer at Initial Presentation: Is It Time for a Paradigm Shift?Ken Kazahaya, Kara K Prickett, Vera A Paulson, et al.
Cancer|October 20, 2020
Benefit of delayed primary excision in rhabdomyosarcoma: A report from the Children's Oncology GroupTimothy B Lautz, Yueh-Yun Chi, Minjie Li, et al.
The American Journal of Surgical Pathology|March 13, 2014
Myogenin, AP2β, NOS-1, and HMGA2 are surrogate markers of fusion status in rhabdomyosarcoma: a report from the soft tissue sarcoma committee of the children's oncology groupErin R Rudzinski, James R Anderson, Elizabeth R Lyden, et al.
Pediatric Blood & Cancer|January 13, 2016
Histology, Fusion Status, and Outcome in Alveolar Rhabdomyosarcoma With Low-Risk Clinical Features: A Report From the Children's Oncology GroupMichael A Arnold, James R Anderson, Julie M Gastier-Foster, et al.
The Lancet. Oncology|June 27, 2024
Addition of temsirolimus to chemotherapy in children, adolescents, and young adults with intermediate-risk rhabdomyosarcoma (ARST1431): a randomised, open-label, phase 3 trial from the Children's Oncology GroupAbha A Gupta, Wei Xue, Douglas J Harrison, et al.
JCO Precision Oncology|May 6, 2026
<i>NTRK</i> Gene Fusions: A Compendium of Fusion Partners and Tumor TypesSoo-Ryum Yang, Matteo Repetto, Erin R Rudzinski, et al.
Pageof 9